130 related articles for article (PubMed ID: 23050666)
1. Neuroendocrine differentiation in head and neck squamous cell carcinoma.
Schartinger VH; Falkeis C; Laimer K; Sprinzl GM; Riechelmann H; Rasse M; Virgolini I; Dudás J
J Laryngol Otol; 2012 Dec; 126(12):1261-70. PubMed ID: 23050666
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
3. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
[TBL] [Abstract][Full Text] [Related]
8. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
10. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
13. Basaloid squamous cell carcinoma of the head and neck: report of 18 cases.
Choussy O; Bertrand M; François A; Blot E; Hamidou H; Dehesdin D
J Laryngol Otol; 2011 Jun; 125(6):608-13. PubMed ID: 21450130
[TBL] [Abstract][Full Text] [Related]
14. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
Gires O; Mack B; Rauch J; Matthias C
Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
Culhaci N; Metin K; Copcu E; Dikicioglu E
BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
[TBL] [Abstract][Full Text] [Related]
16. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma showing thymus-like differentiation (CASTLE) with neuroendocrine differentiation.
Yamazaki M; Fujii S; Daiko H; Hayashi R; Ochiai A
Pathol Int; 2008 Dec; 58(12):775-9. PubMed ID: 19067852
[TBL] [Abstract][Full Text] [Related]
18. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of neuroendocrine markers in angiosarcoma: a potential diagnostic pitfall.
Tessier Cloutier B; Costa FD; Tazelaar HD; Folpe AL
Hum Pathol; 2014 Aug; 45(8):1618-24. PubMed ID: 24846674
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]